unknown
Stage
About
Hula Therapeutics is a clinical-stage immunotherapy company that identifies highly specific tumor targets presented via the Human Leukocyte Antigen system and engineers therapies to maximize tumor killing while minimizing healthy tissue toxicity for solid tumors.
Explore Hula Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.